The rejection of Acomplia doesn’t make crusader Steven Nissen look good:
That means it’s at least the second time in under a year that Steven Nissen has been wrong about the promise of new drugs. Nissen, of course, is the well-known Cleveland Clinic cardiologist whose efforts were largely responsible for toppling Vioxx, and he just co-authored a NEJM study raising serious doubts about Avandia.
He was also optimistic about Pfizer-dud torcetrapib. (via WSJ Health Blog)
